Milestone Pharmaceuticals IncNASDAQ:MIST
- LAST PRICE1.5800
- TODAY'S CHANGE (%)-0.0800 (-4.8193%)
- Bid / Lots1.5700/ 1
- Ask / Lots1.6900/ 1
- Open / Previous Close1.6600 / 1.6600
- Day Range
- 52 Week Range
- Volume253,033
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MIST |
|---|---|---|
| 09:32 ET | 478 | 1.66 |
| 09:38 ET | 600 | 1.65 |
| 10:03 ET | 600 | 1.65 |
| 10:12 ET | 1000 | 1.66 |
| 10:21 ET | 5547 | 1.65 |
| 10:24 ET | 7549 | 1.62 |
| 10:28 ET | 300 | 1.62 |
| 10:33 ET | 3090 | 1.6532 |
| 10:35 ET | 2100 | 1.62 |
| 10:37 ET | 513 | 1.6199 |
| 10:39 ET | 1463 | 1.62 |
| 10:44 ET | 112 | 1.62 |
| 10:46 ET | 2375 | 1.65 |
| 10:50 ET | 3300 | 1.63 |
| 10:53 ET | 1600 | 1.64 |
| 10:57 ET | 42600 | 1.6633 |
| 11:00 ET | 2700 | 1.67 |
| 11:40 ET | 100 | 1.66 |
| 11:42 ET | 100 | 1.66 |
| 12:07 ET | 100 | 1.6764 |
| 12:16 ET | 1497 | 1.67 |
| 12:21 ET | 210 | 1.65 |
| 12:39 ET | 1212 | 1.65 |
| 12:45 ET | 3000 | 1.62 |
| 12:56 ET | 4250 | 1.64 |
| 12:57 ET | 800 | 1.62 |
| 01:08 ET | 719 | 1.63 |
| 01:28 ET | 100 | 1.6295 |
| 01:39 ET | 250 | 1.63 |
| 02:08 ET | 300 | 1.62 |
| 02:26 ET | 100 | 1.62 |
| 02:33 ET | 3053 | 1.62 |
| 02:36 ET | 5463 | 1.62 |
| 02:40 ET | 300 | 1.62 |
| 02:42 ET | 100 | 1.63 |
| 02:51 ET | 2350 | 1.6199 |
| 02:54 ET | 2700 | 1.62 |
| 02:56 ET | 3957 | 1.62 |
| 03:03 ET | 1200 | 1.62 |
| 03:05 ET | 1910 | 1.6199 |
| 03:07 ET | 6000 | 1.6097 |
| 03:25 ET | 3356 | 1.61 |
| 03:30 ET | 4896 | 1.5996 |
| 03:34 ET | 958 | 1.59 |
| 03:36 ET | 2600 | 1.56 |
| 03:43 ET | 1708 | 1.57 |
| 03:45 ET | 1800 | 1.58 |
| 03:48 ET | 7955 | 1.58 |
| 03:50 ET | 9537 | 1.555 |
| 03:52 ET | 17379 | 1.5497 |
| 03:54 ET | 72165 | 1.53 |
| 03:56 ET | 3000 | 1.5746 |
| 03:57 ET | 2581 | 1.6 |
| 03:59 ET | 985 | 1.58 |
Apr 17, 2024
Milestone(R) Pharmaceuticals to Present Data on Etripamil at the Preventative Cardiovascular Nursing Symposium, from 8:00AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:00AM ET on Wednesday Apr 17, 2024 by Dow Jones
Apr 8, 2024
Apr 3, 2024
Milestone(R) Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference, from 8:00AM ET on Wednesday Apr 03, 2024 by Dow Jones
8:00AM ET on Wednesday Apr 03, 2024 by Dow Jones
Mar 28, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Milestone Pharmaceuticals Inc | 88.2M | -1.1x | --- |
BioXcel Therapeutics Inc | 90.6M | -0.4x | --- |
Allovir Inc | 89.0M | -0.4x | --- |
PMV Pharmaceuticals Inc | 86.9M | -1.2x | --- |
Allakos Inc | 89.6M | -0.5x | --- |
Sellas Life Sciences Group Inc | 86.7M | -1.1x | --- |
Company Information
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.
Contact Information
- Headquarters
- 420-1111 boul. Dr.-Frederik-PhilipsMONTREAL, QC, Canada H4M 2X6
- Phone
- 514-336-0444
- Fax
- 514-336-0444
Executives
- Non-Executive Independent Chairman of the Board
- Robert Wills
- President, Chief Executive Officer, Director
- Joseph Oliveto
- Chief Financial Officer, Executive Vice President of Corporate Development
- Amit Hasija
- Chief Operating Officer
- Jeffrey Nelson
- Chief Medical Officer
- David Bharucha
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $88.2M |
|---|---|
Revenue (TTM) | $1.0M |
Shares Outstanding | 53.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.77 |
EPS | $-1.39 |
Book Value | $0.50 |
P/E Ratio | -1.1x |
Price/Sales (TTM) | 88.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -6,109.80% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
